View : 527 Download: 0
Synthesis and biological evaluation of 2-benzylamino-4(5)-(6-methylpyridin- 2-yl)-5(4)-([1,2,4]triazolo[1,5-a]-pyridin-6-yl)thiazoles as transforming growth factor-β type 1 receptor kinase inhibitors
- Title
- Synthesis and biological evaluation of 2-benzylamino-4(5)-(6-methylpyridin- 2-yl)-5(4)-([1,2,4]triazolo[1,5-a]-pyridin-6-yl)thiazoles as transforming growth factor-β type 1 receptor kinase inhibitors
- Authors
- Krishnaiah M.; Jin C.H.; Sreenu D.; Subrahmanyam V.B.; Rao K.S.; Son D.-H.; Park H.-J.; Kim S.W.; Sheen Y.Y.; Kim D.-K.
- Ewha Authors
- 신윤용; 김대기; 김승원
- SCOPUS Author ID
- 신윤용
; 김대기
; 김승원

- Issue Date
- 2012
- Journal Title
- European Journal of Medicinal Chemistry
- ISSN
- 0223-5234
- Citation
- European Journal of Medicinal Chemistry vol. 57, pp. 74 - 84
- Indexed
- SCI; SCIE; SCOPUS

- Document Type
- Article
- Abstract
- A series of 2-benzylamino-4(5)-(6-methylpyridin-2-yl)-5(4)-([1,2,4] triazolo[1,5-a]pyridin-6-yl)thiazoles 12a-ab, 13a, 13b, and 18a-d has been synthesized and evaluated for their ALK5 inhibitory activity in an enzyme assay and in a cell-based luciferase reporter assay. The N-(3-fluorobenzyl)-4-(6- methylpyridin-2-yl)-5-([1,2,4]triazolo[1,5-a]pyridin-6-yl)thiazol-2-amine (12b) inhibited ALK5 phosphorylation with an IC50 value of 7.01 nM and showed 61% inhibition at 30 nM in a luciferase reporter assay using HaCaT cells permanently transfected with p3TP-luc reporter construct. © 2012 Elsevier Masson SAS. All rights reserved.
- DOI
- 10.1016/j.ejmech.2012.09.011
- Appears in Collections:
- 약학대학 > 약학과 > Journal papers
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML